skip navigation
Home News Resources Donations Contact Us

Faculty

Staff

Nathan Thielman, MD, MPH

Duke University Medical Center
Dr. Thielman is associate professor of medicine in the Division of Infectious Diseases and International Health and medical director of the Infectious Diseases Clinic at Duke. A graduate of Wheaton College, Dr. Thielman completed both medical school and internal medicine residency training at Duke. He earned a master's degree in public health from the University of North Carolina at Chapel Hill and finished infectious diseases training at the University of Virginia.

Dr. Thielman has a longstanding interest in international health and has either provided medical care or conducted clinically relevant medical research in Honduras, Brazil, Bangladesh, Kenya, and Tanzania. His research interests include infectious diarrhea and a breadth of issues related to HIV infection in resource-poor settings, particularly in the Kilimanjaro region of Tanzania . With collaborators from Duke and Tanzania, recent research activities have described cost-effective strategies for HIV voluntary counseling and testing in a community-based organization, the morbidity and mortality of AIDS-related complications at Kilimanjaro Christian Medical Centre, regionally relevant clinical staging criteria to guide treatment decisions, and early experiences implementing antiretroviral therapy in the Kilimanjaro region. He is principal investigator for the Tuberculosis and HIV Immune Reconstitution Syndrome Trial (THIRST), which is assessing the interactions between HIV and tuberculosis among patients beginning therapy for both. Dr. Thielman serves as the U.S.-based director for training for Duke's AIDS International Training and Research Program (AITRP) and is the co-director of biostatistics and epidemiology for Duke's International Studies of AIDS-associated Coinfections (ISAAC) unit. He was the recipient of a 2003-2004 Fulbright Research Scholar Award for his work in Tanzania and serves on the National Advisory Allergy and Infectious Diseases Council of the NIH, the AIDS Research Advisory Committee, NIAID/NIH, and the CDC/ HRSA Advisory Committee on HIV and STD Prevention and Treatment.